Finasteride topical - Acrux
Alternative Names: Finasteride MDTSLatest Information Update: 02 Oct 2021
At a glance
- Originator Acrux
- Class Androstenes; Antiacnes; Antiandrogens; Antineoplastics; Azasteroids; Skin disorder therapies; Small molecules
- Mechanism of Action Cholestenone 5 alpha-reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alopecia
Most Recent Events
- 02 Feb 2011 Discontinued - Preclinical for Alopecia in Australia (Topical)
- 02 Feb 2011 Discontinued - Preclinical for Alopecia in USA (Topical)
- 23 May 2005 Acrux and Napa Biosciences have entered into an exclusive worldwide licensing agreement to develop and commercialise certain prescription and over-the-counter dermatology products for various skin disorders, including alopecia